Cargando…

Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study

BACKGROUND: The Amyloid/Tau/Neurodegeneration (ATN) framework has been proposed as a means of evidencing the biological state of Alzheimer’s disease (AD). Predicting ATN status in pre-dementia individuals therefore provides an important opportunity for targeted recruitment into AD interventional stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvin, Catherine M., de Boer, Casper, Raymont, Vanessa, Gallacher, John, Koychev, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650169/ https://www.ncbi.nlm.nih.gov/pubmed/33168064 http://dx.doi.org/10.1186/s13195-020-00711-5

Ejemplares similares

Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
por: Ingala, Silvia, et al.
Publicado: (2021)

European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol
por: Solomon, Alina, et al.
Publicado: (2018)

Longitudinal change in ATN biomarkers in cognitively normal individuals
por: Ebenau, Jarith L., et al.
Publicado: (2022)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
por: Duong, Michael Tran, et al.
Publicado: (2022)

Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach
por: Koychev, Ivan, et al.
Publicado: (2023)

Age differences in the association between sleep and Alzheimer's disease biomarkers in the EPAD cohort
por: Naismith, Sharon L., et al.
Publicado: (2022)

The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow
por: Lorenzini, Luigi, et al.
Publicado: (2022)

O011 Associations between sleep and Alzheimer’s disease biomarkers within the EPAD cohort
por: Naismith, S, et al.
Publicado: (2021)

ePAD: An Image Annotation and Analysis Platform for Quantitative Imaging
por: Rubin, Daniel L., et al.
Publicado: (2019)

Involving research participants in a pan-European research initiative: the EPAD participant panel experience
por: Gregory, S., et al.
Publicado: (2020)

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
por: Vermunt, Lisa, et al.
Publicado: (2020)

Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
por: Saunders, Tyler S., et al.
Publicado: (2022)

Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders
por: Eckerström, C., et al.
Publicado: (2021)

Exploring the ATN classification system using brain morphology
por: Heinzinger, Nils, et al.
Publicado: (2023)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
por: Delmotte, Koen, et al.
Publicado: (2021)

The association of serum uric acid with cognitive impairment and ATN biomarkers
por: Huang, Shan, et al.
Publicado: (2022)

Surgical Outcomes of Myopic Foveoschisis According to the ATN Classification System
por: Fang, Dong, et al.
Publicado: (2022)

ATN profile classification across two independent prospective cohorts
por: Peretti, Débora E., et al.
Publicado: (2023)

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease
por: Koychev, Ivan, et al.
Publicado: (2019)

Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
por: Saleh, Rasha N. M., et al.
Publicado: (2023)

VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2020)

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
por: Ebenau, Jarith L., et al.
Publicado: (2020)

Mediterranean diet score is associated with greater allocentric processing in the EPAD LCS cohort: A comparative analysis by biogeographical region
por: Gregory, Sarah, et al.
Publicado: (2022)

Dementias Platform UK Clinical Studies and Great Minds Register: protocol of a targeted brain health studies recontact database
por: Koychev, Ivan, et al.
Publicado: (2020)

Prognostic value of imaging-based ATN profiles in a memory clinic cohort
por: Peretti, Débora E., et al.
Publicado: (2023)

Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
por: Moll, Frans, et al.
Publicado: (2018)

Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
por: Toniolo, Sofia, et al.
Publicado: (2023)

Association between ATN profiles and mortality in a clinical cohort of patients with cognitive disorders
por: Régy, Mélina, et al.
Publicado: (2023)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

YOLOv5-Atn: An Algorithm for Residual Film Detection in Farmland Combined with an Attention Mechanism
por: Lin, Ying, et al.
Publicado: (2023)

A Case of Congenital Hypotonia and Developmental Delay in an Individual with a De Novo Variant Outside of the Canonical HX-Motif of ATN1
por: Makarova, Elizaveta, et al.
Publicado: (2023)

Bilingualism: A Global Public Health Strategy for Healthy Cognitive Aging
por: Mendis, Sahan Benedict, et al.
Publicado: (2021)

Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
por: Gauthier, S., et al.
Publicado: (2018)

Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study
por: Song, Rao, et al.
Publicado: (2022)

Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials
por: Naorungroj, Thummaporn, et al.
Publicado: (2022)

The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
por: Beddingfield, Brandon J., et al.
Publicado: (2020)

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions
por: Mahmood, Niaz, et al.
Publicado: (2020)

Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
por: Rabbani, Gulam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9i6b6a2eibeq15kjpp8v8rat5q